CNC vs CPHI · P/E 8.4, rev $163.07B vs rev $4.5M
Centene Corp (CNC) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the CNC and CPHI stock pages for the full models.
Not investment advice.